首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   29772篇
  免费   2187篇
  国内免费   145篇
耳鼻咽喉   93篇
儿科学   1664篇
妇产科学   676篇
基础医学   2749篇
口腔科学   117篇
临床医学   2968篇
内科学   9463篇
皮肤病学   501篇
神经病学   2352篇
特种医学   246篇
外科学   3232篇
综合类   695篇
现状与发展   1篇
一般理论   6篇
预防医学   2621篇
眼科学   1040篇
药学   1247篇
  2篇
中国医学   62篇
肿瘤学   2369篇
  2024年   44篇
  2023年   280篇
  2022年   260篇
  2021年   394篇
  2020年   370篇
  2019年   149篇
  2018年   551篇
  2017年   560篇
  2016年   646篇
  2015年   632篇
  2014年   530篇
  2013年   844篇
  2012年   2382篇
  2011年   2647篇
  2010年   916篇
  2009年   889篇
  2008年   2762篇
  2007年   2641篇
  2006年   2279篇
  2005年   2394篇
  2004年   2422篇
  2003年   2530篇
  2002年   1955篇
  2001年   1437篇
  2000年   324篇
  1999年   168篇
  1998年   227篇
  1997年   137篇
  1996年   103篇
  1995年   63篇
  1994年   78篇
  1993年   43篇
  1992年   44篇
  1991年   36篇
  1990年   42篇
  1989年   37篇
  1988年   40篇
  1987年   39篇
  1986年   33篇
  1985年   25篇
  1984年   25篇
  1983年   13篇
  1982年   20篇
  1981年   22篇
  1980年   13篇
  1979年   9篇
  1978年   10篇
  1975年   5篇
  1974年   6篇
  1970年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
We thank Dr Villata et al. for their thought-provoking comments.Their concern about the suitableness to choose combined endpointsin clinical trials deserves some comment.  相似文献   
62.
Proper management of Helicobacter pylori infection in clinical practice--when supported by evidence-based data--is expected to produce substantial cost-efficacy advantages. This consideration has prompted the Cervia Working Group to organise a meeting of experts to update the National Guidelines on the diagnosis and treatment of H. pylori infection in Italy. Recommendations in the new European Guidelines were considered in the National setting, here in the light of factors such as the incidence of gastric cancer and gastric lymphoma, the accessibility to different diagnostic tools, the prevalence of bacterial resistance against antibiotics, and the availability of different drugs. The main revisions in respect to the previous guidelines include H. pylori eradication in non-ulcer dyspepsia patients and in non-steroidal, anti-inflammatory drug users, as well as in patients with idiopathic thrombocytopenic purpura and iron deficiency anaemia. The stool antigen test is now accepted as a valid test for confirmation of H. pylori eradication following therapy. New therapeutic approaches have been recommended for both first- (sequential therapy) and second-line (levofloxacin-based) treatment in our country.  相似文献   
63.
64.
Bronchiolitis obliterans syndrome (BOS) is the limiting factor to long-term survival after lung transplantation. Previous studies suggested respiratory viral tract infections are associated with the development of BOS. To identify the impact of virus detection in bronchoalveolar lavage (BAL) fluid, we analyzed BAL samples from 87 consecutive lung transplant recipients for human herpesvirus (HHV)-6, Epstein-Barr virus, Herpes simplex virus 1/2, Cytomegalovirus, respiratory syncytical virus and adenovirus by PCR. Acute rejection, BOS and death were recorded for a mean follow-up time of 3.27 +/- 0.47 years. Results of PCR analysis and other potential risk factors were entered into a Cox regression analysis of BOS predictors and death. Only acute rejection was a distinct risk factor for BOS of all stages, death and death from BOS. HHV-6 was detected in 20 patients. Univariate and multivariate analysis revealed that HHV-6 was associated with an increased risk to develop BOS > orb = stage 1 and death, separate from the risk attributable to acute rejection. Identification of HHV-6 DNA in BAL fluid is a potential risk factor for BOS. Our results warrant further studies to elucidate a possible causal link between HHV-6 and BOS.  相似文献   
65.
66.
研究地西泮、苯巴比妥、普萘洛尔和西咪替丁对地西泮氧化代谢的影响及其药酶蛋白的初步分析,应用HPLC,SDS聚丙烯酰胺凝胶电泳和薄层扫描测定地西泮及其代谢物,并对大鼠肝微粒体和酶蛋白进行分离和含量测定。结果表明地西泮、普萘洛尔和西咪替丁使肝微粒体中P450含量明显降低。地西泮和普萘洛尔明显抑制地西泮C3羟化活性,大剂量普萘洛尔尚能抑制地西泮N脱甲基。苯巴比妥明显诱导P450生成,增强地西泮N脱甲基和C3羟化酶活性及分子量为51,000和59,000的电泳蛋白带,而地西泮、普萘洛尔则呈抑制作用。并发现,地西泮N脱甲基酶活性和分子量为59,000蛋白含量呈线性相关(P<0.05),而C3羟化酶活性则与51,000蛋白含量呈线性相关(P<0.01)。因此地西泮C3羟化代谢可能与51,000的P450酶蛋白有关,而N脱甲基代谢则可能与59,000的P450酶蛋白有关。  相似文献   
67.
Chlamydia trachomatis, the causative agent of trachoma, affecting hundreds of millions of people, is now recognized as a major cause of sexually transmitted disease. In many countries chlamydial infection now outstrips gonorrhoea as the major cause of genital tract infection. Chlamydial urethritis and cervicitis are frequently complicated by ascending infection involving the endometrium, the fallopian tubes and epididymis. This often results in serious reproductive sequelae, e.g., infertility in the female and ectopic pregnancy. Extra-genital manifestations of chlamydial infection may occur involving the eyes (follicular conjunctivitis), joints (arthritis), and distal intestinal tract. Infection of the newborn child during birth may result in ocular or lung disease.  相似文献   
68.
河南省传染性非典型肺炎患者胸部X线表现   总被引:1,自引:1,他引:0  
目的 :探讨传染性非典型肺炎的X线表现及变化规律。方法 :对河南省临床诊断的 1 5例患者发病后不同时间的系列胸片和CT进行回顾性分析。结果 :1 5例胸部X线病灶初始形态为斑片状 1 1例 (73.3% ) ,大片状 4例 (2 6 .7% ) ;双侧 9例 (6 0 .0 % ) ,单侧 6例 (4 0 .0 % ) ,均为中、下肺野 (1 0 0 % )。动态观察发现病变进展快 ,病变发展到高峰期时间为 4~ 1 4d , x±s(7.7± 3.2 )d ,双侧 1 3例 (86 .7% ) ,单侧 2例 (1 3.3% ) ,两肺叶及两肺叶以上病变者 1 4例 (93.3% )。病变开始吸收时间为 6~ 2 1d , x±s(1 1 .3± 4 .1 )d ;完全或基本吸收时间 8~ 2 6d , x±s(1 6 .4± 5 .0 )d。1 5例经治疗均痊愈出院。住院时间 1 8~ 4 2d , x±s(31 .9± 7.9)d。 结论 :传染性非典型肺炎的胸部X线特点为急性双侧或单侧多叶炎性浸润阴影 ,以中、下野常见 ,进展迅速 ,及时复查胸部X线对临床诊断及判断病情具有重要价值。  相似文献   
69.
Abstract. The objective of the present study was to compare the calcium set-points of E. M. Brown and A. M. Parfitt obtained by sequential citrate and calcium clamp in patients with primary hyperparathyroidism and healthy controls. Twenty-six patients with primary hyperparathyroidism were investigated and compared to 22 healthy volunteers. All participants were investigated by sequential calcium lowering and raising comprising the following four phases: Phase (1) blood ionized calcium lowering of about 0·20 mmol l-1; phase (2) steady-state (relative) hypocalcaemia of blood ionized calcium 0·20 mmol l-1 below baseline; phase (3) blood ionized calcium is raised to about 0·20 mmol l-1 above baseline; and phase (4) (relative) hypercalcaemia of blood ionized calcium 0·20 mmol l-1 above baseline. Serum parathyroid hormone (1–84) was measured by an immunoradiometric assay. Blood ionized calcium was measured by a calcium selective electrode. We found the calcium set-points of Parfitt to be 1·42 mmol l-1 (SD 0·12, n= 52) vs. 1·25 mmol l-1 (SD 0·04, n= 44) in patients and controls, respectively (P < 0·001). The calcium set-points of Brown were 1·32 mmol l-1 (SD 0·10, n= 26) vs. 1·13 mmol l-1 (SD 0·04, n= 22), respectively (P < 0·001). By comparing the calcium set-points of Parfitt and Brown, a strikingly good correlation was observed, in patients (r= 0·91, P < 0·001) and in controls (r= 0·85, P < 0·001). We demonstrate in this paper in vivo that Brown's and Parfitt's calcium set-points are raised in primary hyperparathyroidism and return to normal following parathyroidectomy. The values for Brown's and Parfitt's calcium set-points are significantly different, but strikingly well correlated, supporting the view that Brown and Parfitt describe two different points on the same sigmoidal curve, corresponding to 50% and about 85% inhibition of PTH maximum, respectively. The mathematical form of the sigmoidal curve between blood ionized calcium and parathyroid hormone is very similar in primary hyperparathyroidism and normal humans.  相似文献   
70.
全国哨点监测性病流行情况初步分析(1993-1996)   总被引:4,自引:0,他引:4  
目的  了解我国性病的现况、流行趋势和有关因素 ,作为制订性病防治规划的依据。方法  我国在 1 993~ 1 996年建立了性病哨点监测系统。该系统在原有性病发病较高的 1 6个城市监测点的基础上进行调整 ,在全国建立了 2 6个性病监测哨点。对哨点加强管理 (如督导和反馈 ) ,收集完整的监测资料 ,并进行专项调查。结果  4年内哨点监测系统共报告性病 2 0 2 86 6例 ,年平均发病率为 1 41 .46 / 1 0万 ,发病率逐年增长 ,但其速度较过去有所减慢。报告的病例男性多于女性 ,其性别比有逐年下降趋势。 2 0~ 39岁组患者占病例数的 82 .37% ,但儿童性病比过去明显增加。城市哨点发病率最高( 1 81 .86 / 1 0万 )。淋病仍为优势病种 ,但其发病呈逐年下降趋势 ;梅毒增加较快 (包括儿童梅毒 )。此系统已开始有 HIV/ AIDS病例的个别报告。在传染源中 ,暗娼占有相当高的比例。结论  哨点监测系统由于加强了管理 ,能较准确地描述当地的性病流行情况 ,特别是其流行趋势。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号